Global Synthetic Biology 2018 by Analysis, Sales Revenue, Gross Margin, Main Products and Forecast 2023Healthcare TrendsGlobal Synthetic Biology Industry 2018 presents an executive level blueprint of the global Synthetic Biology market. This is an anal… Continue reading
Global Synthetic Biology 2018 by Analysis, Sales Revenue, Gross Margin, Main Products and Forecast 2023Healthcare TrendsGlobal Synthetic Biology Industry 2018 presents an executive level blueprint of the global Synthetic Biology market. This is an anal… Continue reading
The Daily GazetteSeattle man is first adult to get new gene therapy for visionThe Daily GazetteStill, he refused to obsess over scientific advances. “I made it a point not to go down those rabbit holes, to be chasing that pipe dream,” Willis said. Neve… Continue reading
Synthetic Biology Tools Market Global Top Manufacturers 2018 …Facts of WeekMarketNReports from its Database gives research study on “Synthetic Biology Tools market” reports. It offers the comparative assesment of Synthetic Biology Tools market and co… Continue reading
|
JF’s Core Biotech Buys #10: Incyte Disappoints, Optimism Returns To Gene Therapy And A New Position
Seeking Alpha The rollercoaster ride in the gene therapy space (pessimism due to clinical hold/safety fears followed by optimism over Novartis acquiring AveXis) has been an interesting case study to watch. We took advantage of undeserved pessimism by filling out … |
HeraldScotland |
Scots lab workers for stem cell firm Precious Cells were kept in dark over firm’s imminent collapse
HeraldScotland Scots workers were deliberately left in the dark about the imminent collapse of the biotech firm they worked for, then had their contracts terminated after two and a half months in limbo. Staff at the London end of the company Precious Cells … |
HeraldScotland |
Scots lab workers for stem cell firm Precious Cells were kept in dark over firm’s imminent collapse
HeraldScotland Scots workers were deliberately left in the dark about the imminent collapse of the biotech firm they worked for, then had their contracts terminated after two and a half months in limbo. Staff at the London end of the company Precious Cells … |